Kose, FatihAlemdaroglu, S.Mertsoylu, H.Besen, A.Guler, O.Simsek, S.Erbay, G.Onal, C.Celik, H.2020-11-022020-11-0220190145-2126http://hdl.handle.net/11727/4989enginfo:eu-repo/semantics/closedAccessClinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapseConference Object85S34S34000489290100040